The Claim
Staphylococcus lentus, a bacterial species enriched in the gut of mice exposed to 7-ketositosterol and in patients with ulcerative colitis, directly worsens experimental colitis in mice by producing a protein (LPDP) that binds to PDLIM3 and activates the p38MAPK/NF-κB inflammatory pathway.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
The bacterium Staphylococcus lentus produces a protein called LPDP that binds to PDLIM3 and triggers the p38MAPK/NF-κB inflammatory pathway, resulting in increased severity of colitis in mice.
See the scientific wording
Staphylococcus lentus, a bacterial species enriched in the gut of mice exposed to 7-ketositosterol and in patients with ulcerative colitis, directly worsens experimental colitis in mice by producing a protein (LPDP) that binds to PDLIM3 and activates the p38MAPK/NF-κB inflammatory pathway.
A gut bacterium called Staphylococcus lentus releases a protein that latches onto a receptor in the gut lining, turning on a molecular switch that triggers inflammation. This switch causes the gut cells to produce chemicals that damage the protective barrier, leading to worsening intestinal inflammation.
What the research says
1 studyA specific gut bacteria called Staphylococcus lentus makes a protein that latches onto a receptor in the gut, turning on an inflammation switch — and when scientists blocked that latch, the inflammation got better.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.